Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004050921 | SCV002640953 | uncertain significance | not specified | 2023-11-22 | criteria provided, single submitter | clinical testing | The p.V1679I variant (also known as c.5035G>A), located in coding exon 44 of the KIF1B gene, results from a G to A substitution at nucleotide position 5035. The valine at codon 1679 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Laboratory of Molecular Epidemiology of Birth Defects, |
RCV003154068 | SCV003843803 | likely pathogenic | Ovarian cancer | 2022-01-01 | criteria provided, single submitter | clinical testing |